Supriya Lifescience Limited (SUPRIYA) - Total Liabilities

Latest as of September 2025: Rs1.21 Billion INR ≈ $13.10 Million USD

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has total liabilities worth Rs1.21 Billion INR (≈ $13.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Supriya Lifescience Limited annual equity growth to track the company's year-over-year net asset growth rate.

Supriya Lifescience Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's total liabilities have evolved over time, based on quarterly financial data. See Supriya Lifescience Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Supriya Lifescience Limited Competitors by Total Liabilities

The table below lists competitors of Supriya Lifescience Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Employers Holdings Inc NYSE:EIG	USA	$2.57 Billion
Changchun Zhiyuan New Energy Equipment Co. Ltd SHE:300985	China	CN¥1.71 Billion
Shanghai Bolex Food Technology Co. Ltd. SHG:603170	China	CN¥582.16 Million
Kingsgate Consolidated Ltd AU:KCN	Australia	AU$222.47 Million
BAE Systems plc LSE:BA	UK	GBX25.74 Billion
HOB Biotech Group Corp Ltd SHG:688656	China	CN¥86.13 Million
Strait Innovation Internet Co Ltd SHE:300300	China	CN¥836.14 Million
Renta 4 Banco S.A MC:R4	Spain	€2.38 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Supriya Lifescience Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Supriya Lifescience Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Supriya Lifescience Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Supriya Lifescience Limited (2018–2025)

The table below shows the annual total liabilities of Supriya Lifescience Limited from 2018 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs1.16 Billion ≈ $12.50 Million	+9.15%
2024-03-31	Rs1.06 Billion ≈ $11.45 Million	-12.37%
2023-03-31	Rs1.21 Billion ≈ $13.07 Million	+1.46%
2022-03-31	Rs1.19 Billion ≈ $12.88 Million	-32.68%
2021-03-31	Rs1.77 Billion ≈ $19.13 Million	-5.53%
2020-03-31	Rs1.87 Billion ≈ $20.25 Million	+17.57%
2019-03-31	Rs1.59 Billion ≈ $17.22 Million	-16.50%
2018-03-31	Rs1.91 Billion ≈ $20.63 Million	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$765.64 Million

Rs70.80 Billion INR

Market Cap Rank

#9971 Global

#505 in India

Share Price

Rs879.65

Change (1 day)

+1.46%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50